Physician

Mohamed Altattan, M.D.

According to 2025 Medicare claims, Mohamed Altattan, M.D. (NPI: 1477932093) practices rheumatology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES -MI PLLC (NPI: 1538655469; TIN: 823851171) and primary practice location at 48073-0991. Altattan is affiliated with the Kettering Physician Partners Accountable Care LLC (ACO ID: A5062), participating under the MSSP model.

Altattan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 459 traditional Medicare patients, billed 62,941 HCPCS/CPT codes, and received $737,051 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,442 prescription claims across 465 beneficiaries totaling $1,393,833 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 50 claims. Open Payments data shows 180 records totaling $4,283. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $46,373 to $737,051. Similarly, Part D prescription costs have risen steadily, from $8,108 to $1,393,833. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$369K$737K2018 Medicare payment: $46,373 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $113,003 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $96,648 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $56,622 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $15,324 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $70,529 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $737,051 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018219607$46,373
20195821,686$113,003
20204851,229$96,648
2021249757$56,622
202291195$15,324
20232952,296$70,529
202445962,941$737,051

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$697K$1.4M2015 Drug cost: $8,108 (USD; Tot_Drug_Cst)2016 Drug cost: $16,846 (USD; Tot_Drug_Cst)2017 Drug cost: $15,265 (USD; Tot_Drug_Cst)2018 Drug cost: $27,696 (USD; Tot_Drug_Cst)2019 Drug cost: $41,472 (USD; Tot_Drug_Cst)2020 Drug cost: $23,786 (USD; Tot_Drug_Cst)2021 Drug cost: $73,801 (USD; Tot_Drug_Cst)2022 Drug cost: $252,197 (USD; Tot_Drug_Cst)2023 Drug cost: $255,946 (USD; Tot_Drug_Cst)2024 Drug cost: $1,393,833 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201529107$8,108
201669219$16,846
201754150$15,265
2018120391$27,696
2019252678$41,472
2020151387$23,786
2021159380$73,801
2022136563$252,197
2023195655$255,946
20244652,442$1,393,833

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.7K$5.3K2019 Medicare payment: $2,047 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,323 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,334 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $3,120 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R56$2,047
20201265$3,323
202114100$5,334
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R50$3,120

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more4949$142
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more153153$106
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more181437$98
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes137223$56
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's141276$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept501,400$374,610
Actemra ActpenTocilizumab341,008$165,083
Humira PenAdalimumab19532$134,820
Humira(Cf) PenAdalimumab17476$115,985
EnbrelEtanercept11448$107,331

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R25$2,414
E1392Portable oxygen concentrator, rentalYN/R14$446
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R11$260

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.180$4,283Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mohamed Altattan, M.D.?

Tedicare shows public-source Medicare data for Mohamed Altattan, M.D. (NPI 1477932093), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamed Altattan, M.D. have ACO affiliation data?

Mohamed Altattan, M.D. is shown with ACO affiliation data for Kettering Physician Partners Accountable Care LLC (MSSP, ACO ID A5062).

What billing organization is linked to Mohamed Altattan, M.D.?

Mohamed Altattan, M.D. is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES -MI PLLC (billing NPI 1538655469) in the available physician profile data.

Does Mohamed Altattan, M.D. have Open Payments data?

Mohamed Altattan, M.D. has 180 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.